Hikma Pharmaceuticals USA v Amarin Pharma presents a complex dispute between Amarin, the manufacturer of Vascepa, a ...

Explore the economic and logistical factors driving prescription drug shortages and their impact on global patient care.

The U.S. Supreme Court will hear a case that could clarify when generic drug makers are liable for patent infringement tied ...

Every week through October, we are examining the medical, business and cultural systems that contribute to the dichotomy that is the American health care system — a system that benefits some but costs ...

This article was produced in partnership with The New York Times. Not all drug prices are going up. Amid the public fury over the escalating costs of brand-name medications, the prices of generic ...

Generic drug manufacturers are facing increasing pressure from drug distributors, pharmacy benefit managers, and Indian competitors, leading to downward trends in generic drug prices. Which firms are ...

Forbes contributors publish independent expert analyses and insights. I am a physician and behavioral scientist at Duke University. Brand-name chemotherapy is often incredibly expensive, in excess of ...

Indian drugmakers begin selling generic Ozempic copies at $14 monthly Friday — 88% cheaper than Novo's brand-name version.

Although generic drugs are typically inexpensive, rising prices among some generic drugs in recent years have raised concern. Using Medicaid data, we found that one in five generic drugs sold in the ...

From a more affordable diabetes drug to a surprising cancer connection at home, here's what's making health headlines today.

The Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by prescribing clinicians had been substituted by a generic option, according to ...